Elegantly, this could potentially be achieved through intensified statin use, as one of the lipid-lowering agent properties is to dose-dependently reduce levels of not only LDL—known to also negatively impact the prognosis of ischemic stroke patients—but also CRP and other inflammatory markers (34). Here, CRP is linked to ischemic stroke.